The tumor-enriched expression of ETS1 was most strikingly discernible in the RNA-Seq data from the Cancer Genome Atlas (TCGA), where ETS1 levels were higher in ~80% of the patient tumor samples compared to matched normal tissue (Fig 1C). The gene discussed is ETS1; the disease is neoplasm.